ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Iowa » Internal Medicine

Top Internal Medicine Prescribers in Iowa

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LAURA BUCK MD

Internal Medicine

689

$48.1K

101
45 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $50

PRAVEEN VIKAS MD

Internal Medicine

676

$109K

107
93 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 24%

$161
Average prescription price

Avg: $50

JEROLD ERLANDSON MD

Internal Medicine

650

$43.5K

85
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $50

BHARAT MOTWANI M.D.

Internal Medicine

648

$395K

83
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 24%

$610
Average prescription price

Avg: $50

SONIA CAJIGAL M.D.

Internal Medicine

532

$26K

74
34 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

CHANDAN MITRA MD

Internal Medicine

479

$20.2K

138
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $50

SHAZIA ABBAS MD

Internal Medicine

421

$17.2K

128
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $50

FADI HAMMOUDEH MD

Internal Medicine

388

$50.2K

122
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

64%
prescriptions for brand name drugs

Avg: 24%

$129
Average prescription price

Avg: $50

MARK OBRIEN DO

Internal Medicine

324

$5,949

187
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$18
Average prescription price

Avg: $50

JEAN LORENTZEN D.O.

Internal Medicine

310

$30.6K

38
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 24%

$99
Average prescription price

Avg: $50

GAUTAM KAKADE MD

Internal Medicine

302

$24.8K

103
77 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

53%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 24%

$82
Average prescription price

Avg: $50

CHAD WILLIAMS MD

Internal Medicine

297

$10.7K

34
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$36
Average prescription price

Avg: $50

MAITREYI JANARTHANAN MD

Internal Medicine

209

$3,928

155
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 24%

$19
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank